These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 17054922

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine.
    Tzavara ET, Bymaster FP, Overshiner CD, Davis RJ, Perry KW, Wolff M, McKinzie DL, Witkin JM, Nomikos GG.
    Mol Psychiatry; 2006 Feb; 11(2):187-95. PubMed ID: 16231039
    [Abstract] [Full Text] [Related]

  • 23. [Without treatment the crash threatens].
    Einecke U.
    MMW Fortschr Med; 2009 Jan 29; 151(5):14-6. PubMed ID: 19391404
    [No Abstract] [Full Text] [Related]

  • 24. Improving decision making in the treatment of ADHD.
    Vitiello B.
    Am J Psychiatry; 2008 Jun 29; 165(6):666-7. PubMed ID: 18519529
    [No Abstract] [Full Text] [Related]

  • 25. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.
    Posey DJ, Aman MG, McCracken JT, Scahill L, Tierney E, Arnold LE, Vitiello B, Chuang SZ, Davies M, Ramadan Y, Witwer AN, Swiezy NB, Cronin P, Shah B, Carroll DH, Young C, Wheeler C, McDougle CJ.
    Biol Psychiatry; 2007 Feb 15; 61(4):538-44. PubMed ID: 17276750
    [Abstract] [Full Text] [Related]

  • 26. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
    Huang YS, Guilleminault C, Li HY, Yang CM, Wu YY, Chen NH.
    Sleep Med; 2007 Jan 15; 8(1):18-30. PubMed ID: 17157069
    [Abstract] [Full Text] [Related]

  • 27. Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: comparison with methylphenidate.
    Fumagalli F, Cattaneo A, Caffino L, Ibba M, Racagni G, Carboni E, Gennarelli M, Riva MA.
    Pharmacol Res; 2010 Dec 15; 62(6):523-9. PubMed ID: 20691787
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Attention deficit/hyperactivity disorder: burden of the disease according to subtypes in recently diagnosed children].
    Escobar R, Hervas A, Soutullo C, Mardomingo MJ, Uruñuela A, Gilaberte I.
    Actas Esp Psiquiatr; 2008 Dec 15; 36(5):285-94. PubMed ID: 18830848
    [Abstract] [Full Text] [Related]

  • 30. Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
    Wilens TE.
    J Clin Psychiatry; 2006 Dec 15; 67 Suppl 8():32-8. PubMed ID: 16961428
    [Abstract] [Full Text] [Related]

  • 31. Attention deficit/hyperactivity disorder in adults.
    Moss SB, Nair R, Vallarino A, Wang S.
    Prim Care; 2007 Sep 15; 34(3):445-73, v. PubMed ID: 17868755
    [Abstract] [Full Text] [Related]

  • 32. Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children With ADHD.
    Faraone SV, Wigal SB, Hodgkins P.
    J Atten Disord; 2007 Jul 15; 11(1):74-82. PubMed ID: 17606774
    [Abstract] [Full Text] [Related]

  • 33. [Drugs for attention deficit hyperactivity disorder].
    Montañés-Rada F, Gangoso-Fermoso AB, Martíínez-Granero MA.
    Rev Neurol; 2007 Jul 15; 48(9):469-81. PubMed ID: 19396764
    [Abstract] [Full Text] [Related]

  • 34. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
    Biederman J, Pliszka SR.
    J Pediatr; 2008 Mar 15; 152(3):394-9. PubMed ID: 18280848
    [Abstract] [Full Text] [Related]

  • 35. Attenuation of pharmacologically-induced attentional impairment by methylphenidate in rats.
    Rezvani AH, Kholdebarin E, Cauley MC, Dawson E, Levin ED.
    Pharmacol Biochem Behav; 2009 Mar 15; 92(1):141-6. PubMed ID: 19041337
    [Abstract] [Full Text] [Related]

  • 36. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG, Gerhard T, Shuster J, Zito J, Johnson M, Liu H, Saidi A.
    Ann Pharmacother; 2008 Jan 15; 42(1):24-31. PubMed ID: 18042808
    [Abstract] [Full Text] [Related]

  • 37. Reflective and impulsive reactions in ADHD subtypes.
    Schwenck C, Schmiedeler S, Zenglein Y, Renner T, Romanos M, Jans T, Schneider W, Warnke A.
    Atten Defic Hyperact Disord; 2009 May 15; 1(1):3-10. PubMed ID: 21432574
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Clinical considerations for the diagnosis and treatment of ADHD in the managed care setting.
    Jensen PS.
    Am J Manag Care; 2009 May 15; 15(5 Suppl):S129-40. PubMed ID: 19601688
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.